Trials / Sponsors / Archemix Corp.
Archemix Corp.
Industry · 6 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Terminated | Effect of ARC1779 on Cerebral Microembolism in Patients Undergoing Carotid Endarterectomy Intracranial Embolism, Cerebral Thromboembolism, Carotid Stenosis | Phase 2 | 2009-02-01 |
| Terminated | Clinical Outcome Study of ARC1779 Injection in Patients With Thrombotic Microangiopathy Thrombotic Microangiopathy, Thrombotic Thrombocytopenic Purpura | Phase 2 | 2008-12-01 |
| Withdrawn | A Study of the Pharmacokinetics, Pharmacodynamics, and Safety of ARC1779 Injection in Patients With Von Willeb Von Willebrand Disease | Phase 2 | 2008-10-01 |
| Completed | ARC1779 Injection in Patients With Von Willebrand Factor-Related Platelet Function Disorders Purpura, Thrombotic Thrombocytopenic, Von Willebrand Disease Type-2b | Phase 2 | 2008-01-01 |
| Terminated | Study of ARC1779 in Patients With Acute Myocardial Infarction Undergoing PCI Acute Myocardial Infarction | Phase 2 | 2007-10-01 |
| Completed | Safety, Pharmacokinetics, and Pharmacodynamics of ARC1779 in Healthy Volunteers Thrombosis | Phase 1 | 2006-12-01 |